Dr. Lal PathLabs Limited - Neraca (Quarterly)

Dr. Lal PathLabs Limited
IN ˙ NSEI ˙ INE600L01024
₹ 3,249.50 ↓ -76.25 (-2.29%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Dr. Lal PathLabs Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 7,145 2,443 9,978 3,782 5,259 2,637 7,864 3,609 8,380 2,926
Change (%) -65.81 308.44 -62.10 39.06 -49.85 198.18 -54.10 132.18 -65.08
Assets Current 9,911 11,452 13,088 8,752 8,348 9,731 10,788 11,267 13,256 13,635
Change (%) 15.55 14.29 -33.13 -4.61 16.57 10.86 4.44 17.65 2.86
Assets 15,169 16,613 18,560 23,468 23,020 23,856 24,453 24,560 25,975 27,168
Change (%) 9.52 11.72 26.44 -1.91 3.63 2.50 0.44 5.76 4.59
Liabilities 3,374 3,853 4,509 8,097 7,191 6,860 6,392 5,706 5,623 5,103
Change (%) 14.20 17.02 79.57 -11.19 -4.60 -6.82 -10.73 -1.45 -9.25
Equity 11,795 12,760 14,051 15,371 15,829 16,995 18,061 18,854 20,352 22,065
Change (%) 8.18 10.12 9.39 2.98 7.37 6.27 4.39 7.95 8.42
Liabilities And Stock Equity 15,169 16,613 18,560 23,468 23,020 23,856 24,453 24,560 25,975 27,168
Change (%) 9.52 11.72 26.44 -1.91 3.63 2.50 0.44 5.76 4.59

Source: Capital IQ

Other Listings
IN:539524
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista